SCHEMBL9517820

SCHEMBL9517820

C=Cc1ccccc1S(=O)(=O)[O-].CCCC[P+](CCCC)(CCCC)CCCC

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.34
CA9 Q16790 3/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA7 P43166 2/20 0.32
CA4 P22748 1/20 0.32
DNM1 Q05193 2/20 0.32
MMP1 P03956 4/20 0.32
MMP7 P09237 4/20 0.32
MMP12 P39900 4/20 0.32
MMP13 P45452 4/20 0.32
ACE P12821 3/20 0.32
RECQL P46063 1/20 0.31
BDKRB2 P30411 1/20 0.31
CA14 Q9ULX7 1/20 0.31
CA12 O43570 2/20 0.31
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL5893071 0.83 KCNH2 (0.34) NR1I2CA9RECQLCA12
Cetrimonium SCHEMBL5384565 0.80 DNM1 (0.40) NR1I2DNM1RECQL
SCHEMBL8685606 0.80 DNM1 (0.42) NR1I2DNM1ESR1
SCHEMBL5383904 0.80 DNM1 (0.40) NR1I2DNM1RECQL
SCHEMBL5274177 0.80 DNM1 (0.36) NR1I2DNM1RECQLESR1
Lithium Ion SCHEMBL1252811 0.79 ALDH1A1 (0.40) CA9CA1CA2CA7
Silver SCHEMBL4962791 0.79 ALDH1A1 (0.40) CA9CA1CA2CA7
SCHEMBL3002304 0.79 ALDH1A1 (0.40) CA9CA1CA2CA7CA12
SCHEMBL2997850 0.79 ALDH1A1 (0.40) CA9CA1CA2CA7
SCHEMBL2021507 0.79 ALDH1A1 (0.40) CA9CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME TOSOH FINECHEM CORPORATION (JP) 2025-03-20 US disclosed
CN-118843614-A High-purity 4- (2-bromoethyl) benzenesulfonic acid, high-purity styrenesulfonic acid derived therefrom, polymer thereof, and process for producing these 东曹精细化工株式会社 2024-10-25 CN disclosed
US-10996496-B2 Composite film, device including, and method of forming the same NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2021-05-04 US disclosed
EP-3500890-A1 COMPOSITE FILM, DEVICE INCLUDING, AND METHOD OF FORMING THE SAME Nanyang Technological University (SG) 2019-06-26 EP disclosed
US-20190179176-A1 COMPOSITE FILM, DEVICE INCLUDING, AND METHOD OF FORMING THE SAME NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2019-06-13 US disclosed
EP-0473824-B1 Synthetic resin molded article having good antistatic property and process for preparation thereof MITSUBISHI RAYON CO (JP) 1993-12-29 EP disclosed
US-5175059-A Anionic polymers MITSUBISHI RAYON COMPANY LTD. (JP) 1992-12-29 US disclosed
US-5143675-A Anionic surfactants MISTUBISHI RAYON CO., LTD. (JP) 1992-09-01 US disclosed
US-5106912-A Blend of thermoplastic polymer with anionic resin MITSUBISHI RAYON COMPANY, LTD. (JP) 1992-04-21 US disclosed
EP-0474896-A1 Antistatic thermoplastic resin composition MITSUBISHI RAYON COMPANY LTD. (JP) 1992-03-18 EP disclosed
EP-0473824-A1 Synthetic resin molded article having good antistatic property and process for preparation thereof MITSUBISHI RAYON CO., LTD. (JP) 1992-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME BRPF1, WEE2, WEE1 NR1I2 3699/4885CA9 4280/4885CA1 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.